Combination Therapy Using Chimeric Monoclonal Antibodies Protects Mice from Lethal H5N1 Infection and Prevents Formation of Escape Mutants

Mookkan Prabakaran, Nayana Prabhu, Fang He et al. · 2009

Read Combination Therapy Using Chimeric Monoclonal Antibodies Protects Mice from Lethal H5N1 Infection and Prevents Formation of Escape Mutants by Mookkan Prabakaran, Nayana Prabhu, Fang He et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005672.txt.

Description

Mookkan Prabakaran and colleagues combined lab-made antibodies to fight bird flu in mice, in work published in 2009. H5N1 flu can kill, and recent strains resist the standard antiviral drugs. A single antibody can protect, but the virus may change shape and slip past it.

The team paired chimeric monoclonal antibodies, which are built to home in on the virus. Together, the pair protected mice from a lethal dose of H5N1. The mix also blocked the rise of escape mutants that dodge one antibody alone. Paired antibodies may offer a stronger plan if H5N1 ever spreads widely in people.

Catalog record

CREATORMookkan Prabakaran, Nayana Prabhu, Fang He et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE42 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005672

Browse the full library · About the Tower of Babel